News and Trends 20 Jun 2023 NodThera announces positive inflammatory disease data …there were no serious adverse events (SAEs). Parkinson’s disease program under way by NodThera Development of NT-0796 is now progressing in a pioneering, biomarker-rich phase Ib/IIa study in Parkinson’s disease…. June 20, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 4 Dec 2017 Swiss Biotech Brings in Reinforcements to See Hypertension Drug Through Phase III …hypertension from cardiovascular events that could inflict severe damage to the heart. For those with ongoing heart problems, biotech is working hard to find ways to regenerate the cardiac muscle…. December 4, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Mar 2024 6 biotech companies tackling antibiotic resistance …released in The Lancet. Therefore, the biotech industry now has a major role to play in the discovery and development of novel therapies to overcome the issue of antibiotic resistance… March 7, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 20 Apr 2021 Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in the latest of a series of mergers, acquisitions, and stock market launches taking over the… April 20, 2021 - 5 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 24 Feb 2023 Beyond Biotech podcast 35: Rare Disease Day …This year, the day will be marked by more than 600 events in 106 countries. Replay and The University of Texas MD Anderson Cancer Center create Syena Replay, a genome… February 24, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 22 Oct 2025 PCSK9’s second act: From antibodies to gene editing …saw LDL-C fall by roughly 60% compared to placebo and had a 20% reduction in major cardiovascular events over a median follow-up of just over two years. Around the same time, ODYSSEY OUTCOMES tested… October 22, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2022 CellResearch Corporation announces positive results of phase I diabetic foot ulcer study …in the study experienced any treatment-related adverse events and all subjects saw a reduction in wound size during the treatment period. “These results are encouraging and can be used to… September 19, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 Jun 2023 Six companies that have made their name in the cardiovascular space …ventricular effects while maintaining efficacy in preclinical models. Acticor Biotech Acticor Biotech is a spin-off from the French National Institute of Health and Medical Research (INSERM), and is developing a… June 8, 2023 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 21 Feb 2024 Cytokine release syndrome: how pharma is tackling a 21st century disease …clinic for CRS is American biotech Humanigen’s lenzilumab, which is a monoclonal antibody targeting colony stimulating factor 2 (CSF2)/granulocyte-macrophage colony stimulating factor (GM-CSF). GM-CSFs are proteins secreted by immune cells… February 21, 2024 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2022 FDA approves Heron Therapeutics’ post-op nausea and vomiting drug …24 hours post-surgery and the drug with the fewest adverse events. “With the approval of APONVIE our acute care portfolio now addresses the two most common concerns of patients and… September 19, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jun 2023 New approach improves cancer treatment and minimizes side effects …adverse events (irAEs). The research team, which was led by Tetsuya Kodama from Tohoku University’s Graduate School of Biomedical Engineering, hypothesized that metastatic lymph node-targeted ICB could improve the anti-tumor… June 2, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2023 U.S. approval for psychedelic drug MDMA nears after success in clinic …event or series of events, which can translate into people reliving that trauma through flashbacks and nightmares. Apart from talking therapy and cognitive behavioral therapy, a type of antidepressant known… September 22, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email